A +229% biotech

By kmoffitt, June 10, 2014

So many biotechs, so little time. A biotech, IDIX, gained 229% today on news that Merck will be buying this company that is developing a hepatitis C drug. It always amazes me when I see this happen to a stock that I haven’t seen teased! Hindsight highlights the good, bad, and envious:-)

Leave a Reply

Be the First to Comment!

avatar

wpDiscuz